Muthusamy Shanmugam
HEAD OF R&D, COO-NOVITIUM OPS at ANI Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: ANI Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
ANI Pharmaceuticals Inc. May 21, 202699.7%
-
ANI Pharmaceuticals Inc. May 22, 202599.6%
-
ANI Pharmaceuticals Inc. May 21, 202499.3%
-
ANI Pharmaceuticals Inc. May 23, 202398.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 26, 2026 | ANI Pharmaceuticals Inc. | Grant or award | +11,116 | $77.15 | $857,599 |
| Feb 11, 2026 | ANI Pharmaceuticals Inc. | Shares withheld for tax | −2,898 | $76.25 | $220,973 |
| Aug 21, 2025 | ANI Pharmaceuticals Inc. | Open-market sale | −52,988 | $90.44 | $4,792,235 |
| Aug 20, 2025 | ANI Pharmaceuticals Inc. | Open-market sale | −47,012 | $90.27 | $4,243,773 |
| Aug 15, 2025 | ANI Pharmaceuticals Inc. | Open-market sale | −52,990 | $87.15 | $4,618,079 |
| Aug 14, 2025 | ANI Pharmaceuticals Inc. | Open-market sale | −47,010 | $89.48 | $4,206,455 |
| May 9, 2025 | ANI Pharmaceuticals Inc. | Open-market sale | −700 | $76.83 | $53,781 |
| Feb 12, 2025 | ANI Pharmaceuticals Inc. | Grant or award | +14,362 | — | — |
| Feb 12, 2025 | ANI Pharmaceuticals Inc. | Grant or award | +9,574 | — | — |
| Jul 18, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −2,743 | $62.00 | $170,066 |
| Jul 17, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −14,257 | $63.16 | $900,472 |
| Jul 16, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −22,000 | $64.27 | $1,413,940 |
| Jul 15, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −11,000 | $63.38 | $697,180 |
| Jun 21, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −20,000 | $58.90 | $1,178,000 |
| Jun 20, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −11,447 | $59.86 | $685,217 |
Questions about Muthusamy Shanmugam
What boards is Muthusamy Shanmugam on?
Muthusamy Shanmugam sits on the board of ANI Pharmaceuticals Inc.
How long has Muthusamy Shanmugam served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.